{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:53:56Z","timestamp":1793116436426,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1186\/bcr589","type":"journal-article","created":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T12:27:54Z","timestamp":1051792074000},"source":"Crossref","is-referenced-by-count":129,"title":["Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment"],"prefix":"10.1186","volume":"5","author":[{"given":"Nancy","family":"Boudreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,6,1]]},"reference":[{"key":"593_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995, 1: 27-31.","journal-title":"Nat Med"},{"key":"593_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<207::AID-PATH758>3.0.CO;2-4","volume":"181","author":"K Engels","year":"1997","unstructured":"Engels K, Fox SB, Whitehouse RM, Gatter KC, Harris AL: Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. J Pathol. 1997, 181: 207-212. 10.1002\/(SICI)1096-9896(199702)181:2<207::AID-PATH758>3.0.CO;2-4.","journal-title":"J Pathol"},{"key":"593_CR3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1200\/JCO.1995.13.3.765","volume":"13","author":"G Gasparini","year":"1995","unstructured":"Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol. 1995, 13: 765-782.","journal-title":"J Clin Oncol"},{"key":"593_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.0.CO;2-8","volume":"89","author":"B Linderholm","year":"2000","unstructured":"Linderholm B, Lindh B, Tavelin B, Grankvist K, Henriksson R: p53 and vascular endothelial growth factor expression predicts outcome in 833 patients with primary breast carconoma. Int J Cancer. 2000, 89: 51-62. 10.1002\/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.0.CO;2-8.","journal-title":"Int J Cancer"},{"key":"593_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0955-0674(00)00252-0","volume":"13","author":"BP Elcieri","year":"2001","unstructured":"Elcieri BP, Cheresh DA: Adhesion events in angiogenesis. Curr Opin Cell Biol. 2001, 13: 563-568. 10.1016\/S0955-0674(00)00252-0.","journal-title":"Curr Opin Cell Biol"},{"key":"593_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1083\/jcb.107.4.1589","volume":"107","author":"Y Kubota","year":"1988","unstructured":"Kubota Y, Kleinman HK, Martin GR, Lawley TJ: Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 1988, 107: 1589-1596.","journal-title":"J Cell Biol"},{"key":"593_CR7","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia inducible factor is a basic helix-loop-helix PAS heterodimer regulated by cellular oxygen tension. Proc Natl Acad Sci USA. 1995, 92: 5510-5514.","journal-title":"Proc Natl Acad Sci USA"},{"key":"593_CR8","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","volume":"20","author":"N Masson","year":"2001","unstructured":"Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ: Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 2001, 20: 5197-5206. 10.1093\/emboj\/20.18.5197.","journal-title":"EMBO J"},{"key":"593_CR9","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","volume":"94","author":"PH Maxwell","year":"1997","unstructured":"Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ: Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA. 1997, 94: 8104-8109. 10.1073\/pnas.94.15.8104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"593_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, Keshet E: Role of Hif-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998, 394: 485-490. 10.1038\/28867.","journal-title":"Nature"},{"key":"593_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jnci\/93.4.309","volume":"93","author":"R Bos","year":"2001","unstructured":"Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, van der Wall E: Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst. 2001, 93: 309-314. 10.1093\/jnci\/93.4.309.","journal-title":"J Natl Cancer Inst"},{"key":"593_CR12","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996, 16: 4604-4613.","journal-title":"Mol Cell Biol"},{"key":"593_CR13","doi-asserted-by":"publisher","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","volume":"272","author":"HP Gerber","year":"1997","unstructured":"Gerber HP, Condorelli F, Park J, Ferrara N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia. J Biol Chem. 1997, 272: 23659-23667. 10.1074\/jbc.272.38.23659.","journal-title":"J Biol Chem"},{"key":"593_CR14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0958-1669(99)00024-5","volume":"10","author":"B Olofsson","year":"1999","unstructured":"Olofsson B, Jeltsch M, Eriksson U, Alitalo K: Current biology of Vegf-B and Vegf-C. Curr Opin Biotechnol. 1999, 10: 528-535. 10.1016\/S0958-1669(99)00024-5.","journal-title":"Curr Opin Biotechnol"},{"key":"593_CR15","first-page":"1041","volume":"5","author":"LF Brown","year":"1999","unstructured":"Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF: Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res. 1999, 5: 1041-1056.","journal-title":"Clin Cancer Res"},{"key":"593_CR16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nm740","volume":"8","author":"K Hattori","year":"2002","unstructured":"Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MA, Werb Z, Lyden D, Rafii S: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med. 2002, 8: 841-849.","journal-title":"Nat Med"},{"key":"593_CR17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","volume":"8","author":"A Luttun","year":"2002","unstructured":"Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P: Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002, 8: 831-840.","journal-title":"Nat Med"},{"key":"593_CR18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1084\/jem.174.5.1275","volume":"174","author":"HF Dvorak","year":"1991","unstructured":"Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van de Water L, Senger DR: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med. 1991, 174: 1275-1278.","journal-title":"J Exp Med"},{"key":"593_CR19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","volume":"156","author":"H Hashizume","year":"2000","unstructured":"Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM: Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000, 156: 1363-1380.","journal-title":"Am J Pathol"},{"key":"593_CR20","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y","volume":"80","author":"AJ Guidi","year":"1997","unstructured":"Guidi AJ, Schnitt SJ, Fischer L, Tognazzi K, Harris JR, Dvorak HF, Brown LF: Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer. 1997, 80: 1945-1953. 10.1002\/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y.","journal-title":"Cancer"},{"key":"593_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.bjc.6690681","volume":"81","author":"RR Greb","year":"1999","unstructured":"Greb RR, Maier I, Wallwiener D, Kiesel L: Vascular endothelial growth factor a (Vegf-a) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions. Br J Cancer. 1999, 81: 225-231. 10.1038\/sj.bjc.6690681.","journal-title":"Br J Cancer"},{"key":"593_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/01.ATV.21.1.6","volume":"21","author":"DW Losordo","year":"2001","unstructured":"Losordo DW, Isner JM: Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol. 2001, 21: 6-12.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"593_CR23","first-page":"392","volume":"58","author":"SM Hyder","year":"1998","unstructured":"Hyder SM, Murthy L, Stancel GM: Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res. 1998, 58: 392-395.","journal-title":"Cancer Res"},{"key":"593_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0303-7207(99)00003-9","volume":"149","author":"JK Ruohola","year":"1999","unstructured":"Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Harkonen PL: Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol. 1999, 149: 29-40. 10.1016\/S0303-7207(99)00003-9.","journal-title":"Mol Cell Endocrinol"},{"key":"593_CR25","first-page":"4977","volume":"62","author":"H Buteau-Lozano","year":"2002","unstructured":"Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M: Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res. 2002, 62: 4977-4984.","journal-title":"Cancer Res"},{"key":"593_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF02967545","volume":"9","author":"H Takei","year":"2002","unstructured":"Takei H, Lee ES, Jordan CV: In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer. Breast Cancer. 2002, 9: 39-42.","journal-title":"Breast Cancer"},{"key":"593_CR27","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1054\/bjoc.2001.1810","volume":"84","author":"A Scorilas","year":"2001","unstructured":"Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, Talieri M: Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer. 2001, 84: 1488-1496. 10.1054\/bjoc.2001.1810.","journal-title":"Br J Cancer"},{"key":"593_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000, 2: 737-744. 10.1038\/35036374.","journal-title":"Nat Cell Biol"},{"key":"593_CR29","doi-asserted-by":"publisher","first-page":"39451","DOI":"10.1074\/jbc.M006150200","volume":"275","author":"R Bagheri-Yarmand","year":"2000","unstructured":"Bagheri-Yarmand R, Vadlamudi RK, Wang RA, Mendelsohn J, Kumar R: Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis. J Biol Chem. 2000, 275: 39451-39457. 10.1074\/jbc.M006150200.","journal-title":"J Biol Chem"},{"key":"593_CR30","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1038\/sj.onc.1203685","volume":"19","author":"L Yen","year":"2000","unstructured":"Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, Meloche S, Alaoui-Jamali MA: Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene. 2000, 19: 3460-3469. 10.1038\/sj.onc.1203685.","journal-title":"Oncogene"},{"key":"593_CR31","first-page":"1523","volume":"151","author":"AM Petit","year":"1997","unstructured":"Petit AM, Rak J, Hung MC, Rockwell P, Goldstein N, Fendly B, Kerbel RS: Neutralizing antibodies against epidermal growth factor and ErbB-2\/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol. 1997, 151: 1523-1530.","journal-title":"Am J Pathol"},{"key":"593_CR32","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","volume":"21","author":"E Laughner","year":"2001","unstructured":"Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol. 2001, 21: 3995-4004. 10.1128\/MCB.21.12.3995-4004.2001.","journal-title":"Mol Cell Biol"},{"key":"593_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1083\/jcb.200112015","volume":"158","author":"J Chung","year":"2002","unstructured":"Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM: Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol. 2002, 158: 165-174. 10.1083\/jcb.200112015.","journal-title":"J Cell Biol"},{"key":"593_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1023\/A:1013139022051","volume":"18","author":"MJ Edel","year":"2000","unstructured":"Edel MJ, Harvey JM, Papadimitriou JM: Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases. Clin Exp Metastasis. 2000, 18: 695-702. 10.1023\/A:1013139022051.","journal-title":"Clin Exp Metastasis"},{"key":"593_CR35","first-page":"1008","volume":"8","author":"WL Monsky","year":"2002","unstructured":"Monsky WL, Mouta Carreira C, Tsuzuki Y, Gohongi T, Fukumura D, Jain RK: Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res. 2002, 8: 1008-1013.","journal-title":"Clin Cancer Res"},{"key":"593_CR36","first-page":"747","volume":"62","author":"JC Lee","year":"2002","unstructured":"Lee JC, Kim DC, Gee MS, Saunders HM, Sehgal CM, Feldman MD, Ross SR, Lee WM: Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas. Cancer Res. 2002, 62: 747-755.","journal-title":"Cancer Res"},{"key":"593_CR37","unstructured":"Animal models to study mammary gland development, physiology and tumorigenesis. [ http:\/\/mammary.nih.gov\/models\/index.html ]"},{"key":"593_CR38","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1068327","volume":"295","author":"JL Yu","year":"2002","unstructured":"Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS: Effect of p53 status on tumor response to antiangiogenic therapy. Science. 2002, 295: 1526-1528. 10.1126\/science.1068327.","journal-title":"Science"},{"key":"593_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7","volume":"184","author":"JS de Jong","year":"1998","unstructured":"de Jong JS, van Diest PJ, van der Valk P, Baak JP: Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol. 1998, 184: 53-57. 10.1002\/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7.","journal-title":"J Pathol"},{"key":"593_CR40","first-page":"3924","volume":"57","author":"H Yoshiji","year":"1997","unstructured":"Yoshiji H, Harris SR, Thorgeirsson UP: Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res. 1997, 57: 3924-3928.","journal-title":"Cancer Res"},{"key":"593_CR41","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1172\/JCI118227","volume":"96","author":"PC Brooks","year":"1995","unstructured":"Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA: Anti-integrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995, 96: 1815-1822.","journal-title":"J Clin Invest"},{"key":"593_CR42","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1126\/science.1070200","volume":"296","author":"JD Hood","year":"2002","unstructured":"Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA: Tumor regression by targeted gene delivery to the neovasculature. Science. 2002, 296: 2404-2407. 10.1126\/science.1070200.","journal-title":"Science"},{"key":"593_CR43","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0002-9440(10)65005-5","volume":"156","author":"S Kim","year":"2000","unstructured":"Kim S, Bell K, Mousa SA, Varner JA: Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol. 2000, 156: 1345-1362.","journal-title":"Am J Pathol"},{"key":"593_CR44","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1073\/pnas.94.25.13612","volume":"94","author":"DR Senger","year":"1994","unstructured":"Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M: Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA. 1994, 94: 13612-13617. 10.1073\/pnas.94.25.13612.","journal-title":"Proc Natl Acad Sci USA"},{"key":"593_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1083\/jcb.139.1.257","volume":"139","author":"N Boudreau","year":"1997","unstructured":"Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA: Induction of the angiogenic phenotype by Hox D3. J Cell Biol. 1997, 139: 257-264. 10.1083\/jcb.139.1.257.","journal-title":"J Cell Biol"},{"key":"593_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0102-27","volume":"8","author":"LE Reynolds","year":"2002","unstructured":"Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM: Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med. 2002, 8: 27-34. 10.1038\/nm0102-27.","journal-title":"Nat Med"},{"key":"593_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O'Reilly","year":"1994","unstructured":"O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994, 79: 315-328.","journal-title":"Cell"},{"key":"593_CR48","doi-asserted-by":"publisher","first-page":"29568","DOI":"10.1074\/jbc.274.41.29568","volume":"274","author":"MS O'Reilly","year":"1999","unstructured":"O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, Folkman J, Moses MA: Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem. 1999, 274: 29568-29571. 10.1074\/jbc.274.41.29568.","journal-title":"J Biol Chem"},{"key":"593_CR49","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1074\/jbc.275.11.8051","volume":"275","author":"E Petitclerc","year":"2000","unstructured":"Petitclerc E, Boutaud A, Prestayko A, Xu J, Sado Y, Ninomiya Y, Sarras MP, Hudson BG, Brooks PC: New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem. 2000, 275: 8051-8061. 10.1074\/jbc.275.11.8051.","journal-title":"J Biol Chem"},{"key":"593_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1126\/science.1065298","volume":"295","author":"Y Maeshima","year":"2002","unstructured":"Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R: Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science. 2002, 295: 140-143. 10.1126\/science.1065298.","journal-title":"Science"},{"key":"593_CR51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1083\/jcb.200203064","volume":"158","author":"J Hanai","year":"2002","unstructured":"Hanai J, Gloy J, Karumanchi SA, Kale S, Tang J, Hu G, Chan B, Ramchandran R, Jha V, Sukhatme VP, Sokol S: Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol. 2002, 158: 529-539. 10.1083\/jcb.200203064.","journal-title":"J Cell Biol"},{"key":"593_CR52","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nm1101-1194","volume":"7","author":"D Lyden","year":"2001","unstructured":"Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001, 7: 1194-1201. 10.1038\/nm1101-1194.","journal-title":"Nat Med"},{"key":"593_CR53","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997, 275: 964-967. 10.1126\/science.275.5302.964.","journal-title":"Science"},{"key":"593_CR54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1172\/JCI0214327","volume":"109","author":"M Reyes","year":"2002","unstructured":"Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM: Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002, 109: 337-346. 10.1172\/JCI200214327.","journal-title":"J Clin Invest"},{"key":"593_CR55","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nature00821","volume":"417","author":"HP Gerber","year":"2002","unstructured":"Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, Ferrara N: VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature. 2002, 417: 954-958. 10.1038\/nature00821.","journal-title":"Nature"},{"key":"593_CR56","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","volume":"109","author":"B Heissig","year":"2002","unstructured":"Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002, 109: 625-637.","journal-title":"Cell"},{"key":"593_CR57","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ijc.10336","volume":"99","author":"K Shirakawa","year":"2002","unstructured":"Shirakawa K, Shibuya M, Heike Y, Takashima S, Watanabe I, Konishi F, Kasumi F, Goldman CK, Thomas KA, Bett A, Terada M, Wakasugi H: Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer. 2002, 99: 344-351. 10.1002\/ijc.10336.","journal-title":"Int J Cancer"},{"key":"593_CR58","first-page":"7654","volume":"61","author":"ES de Bont","year":"2001","unstructured":"de Bont ES, Guikema JE, Scherpen F, Meeuwsen T, Kamps WA, Vellenga E, Bos NA: Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic\/ severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma. Cancer Res. 2001, 61: 7654-7659.","journal-title":"Cancer Res"},{"key":"593_CR59","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999, 155: 739-752.","journal-title":"Am J Pathol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr589.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr589\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr589.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T05:15:27Z","timestamp":1518671727000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1186\/bcr589","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]},"article-number":"140"}}